President and CEO Roger Pomerantz sold $2.4M of Seres Therapeutics, Inc.

Sold$2,407,916

$32.52Price

74,049Shares

−29%Stake

What MCRB did after the filing

Prices for MCRB after this filing aren't in yet.

Traded Thu, Jun 2. Filed Mon, Jun 6, 4:30 PM ET, after the close. Not investment advice.